Professor of Medicine, University of Co Cancer Center Outreach Program Director
Oncology
Dr. L Michael Glode, MD
|
|
Give Review
Michael Glode works in the field of Oncology. He researched medicine at University of Texas Southwestern Medical School. He received awards:"CMS Meaningful Use Stage 1 Certification". Michael Glode has written publications. He has 94 publications published with PubMed. The lastest paper is: 'Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo.'
Publications
- Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts.
- Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer.
- Neoadjuvant and adjuvant hormonal and chemotherapy for prostate Cancer.
- Nonseminomatous germ Cell tumor of testis and interrupted treatment.
- Quality of Life After Sipuleucel-T Therapy: Results From a Randomized, Double-blind Study in Patients With Androgen-dependent Prostate Cancer.
- Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate Cancer.
- Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of Bladder cancer.
- Trends in twitter use by physicians at the american society of clinical oncology annual meeting, 2010 and 2011.
- Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study.
- Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate Cancer.
- Metabolic syndrome and prostate Cancer.
- Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary Bladder carcinogenesis in male ICR mice.
- Silibinin synergizes with mitoxantrone to inhibit Cell growth and induce apoptosis in human prostate cancer Cells.
- A comprehensive characterization of the peptide and protein constituents of human seminal fluid.
- The use of trastuzumab in the treatment of hormone refractory prostate Cancer; phase II trial.
- Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor.
- Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-Cell papilloma RT4 Cells.
- Metronomic therapy with cyclophosphamide and dexamethasone for prostate Carcinoma.
- Silibinin sensitizes human prostate carcinoma DU145 Cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
- Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma Cell line.
- High-risk localized prostate Cancer: primary surgery and adjuvant therapy.
- Prostate Cancer on the internet: impact on patients and how technology helps physicians and researchers.
- High Gleason scores and lower Prostate-specific antigen levels in a single institution over the past decade.
- Internet oncology: increased benefit and risk for patients and oncologists.
- A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial.
- Refractory disease, new horizons and patient-physician relationships.
- Flutamide induced lupus.
- In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to Ovarian c...
- Current challenges of gene therapy for prostate Cancer.
- Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic Melanoma.
- Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate Cancer.
- Recombinant Semliki forest virus infects and kills human prostate cancer Cell lines and prostatic duct epithelial Cells ex vivo.
- Gene therapy for B-Cell lymphoma in a SCID mouse model using an immunoglobulin-regulated diphtheria toxin gene delivered by a novel adenovirus-polylysine conjugate.
- Unanticipated side effects from treatment with high-dose mechlorethamine in patients with Malignant melanoma.
- Cysteine auxotrophy of human leukemic lymphoblasts is associated with decreased amounts of intraCellular cystathionase protein.
- High-dose nitrogen mustard (HN2) with autologous nonfrozen bone marrow transplantation in advanced Malignant melanoma. A phase I trial.
- Cystathionase: a potential cytoplasmic marker of hematopoietic differentiation.
- Use of monoclonal antibody to increase sensitivity and specificity in quantitative immunodiffusion assays.
- Reduced gamma-cystathionase protein content in human malignant leukemia Cell lines as measured by immunoassay with monoclonal antibody.
- Treatment of advanced Malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results--Phase I study.
- Scrotal hypothermia and testicular blood flow in the dog. Absence of thermal regulation.
- Malignant melanoma and BCNU.
- A rat model for chemotherapy-induced male infertility.
- Familial leukemia and aplastic Anemia associated with monosomy 7.
- Tumor lysis syndrome following VP-16-213 in chronic myeloid leukemia in blast crisis.
- Long term effects of administration of a gonadotropin-releasing hormone superagonist analog in men with prostatic Carcinoma.
- Autologous marrow transplantation for patients with chronic myelogenous leukemia (CML) in blast crisis.
- Detection of melanoma Cells in bone marrow using monoclonal antibodies. A comparison of fluorescence activated Cell sorting (FACS) and conventional immunofluorescence ...
- Autologous bone marrow transplantation in the therapy of small Cell carcinoma of the lung.
- Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone.
- Androgen depletion/repletion in combination with chemotherapy: strategy for secondary treatment of metastatic prostatic Cancer.
- Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced Cancer of the prostate.
- Clinical effects of gonadotropin-releasing hormone analogue in metastatic Carcinoma of prostate.
- LHRH.
- Use of monoclonal antibody to increase the sensitivity and specificity of precipitating immunoassays and Cell surface binding immunoassays.
- Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice.
- Recovery of blood and bone marrow stem Cells following intense chemotherapy and autologous bone marrow transplantation.
- Regulated expression of a diphtheria toxin A-chain gene transfected into human Cells: possible strategy for inducing cancer Cell suicide.
- Cystathionine metabolism in neuroblastoma.
- Cloning, sequence determination, and expression in transfected Cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain.
- Long-term suppression of luteinizing hormone, follicle-stimulating hormone and testosterone by daily administration of leuprolide.
- Biological implications of androgen dependent changes in proton-NMR relaxation times in rat ventral Prostate.
- The biology of gonadotropin-releasing hormone and its analogs.
- Phase I clinical trial of intracarotid bis-chloroethylnitrosourea (BCNU) and 2' dioxy-5-fluorouridine (FUDR) in Malignant astrocytomas.
- Production of diphtheria toxin CRM228 in B. subtilis.
- Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes.
- Protection of rat spermatogenic epithelium from damage induced by procarbazine chemotherapy.
- Construction and expression of plasmids containing mutated diphtheria toxin A-chain-coding sequences.
- Expression of the diphtheria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B...
- Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected Cells.
- Inhibition of HIV production in Cells containing an integrated, HIV-regulated diphtheria toxin A chain gene.
- Targeted ablation of Pituitary gonadotropes in transgenic mice.
- Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic Carcinoma.
- Expression of diphtheria toxin A-chain in mature B-Cells: a potential approach to therapy of B-lymphoid malignancy.
- Significant contribution of spleen Cells in mediating the lethal effects of endotoxin in vivo.
- HepatoBiliary metabolism and excretion of adriamycin (ADR) in man [proceedings].
- Genetic control of B Cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or alleles.
- gamma-Cystathionase in normal and leukemic Cells.
- Defective prostaGlandin synthesis by C3H/HeJ mouse macrophages stimulated with endotoxin preparations.
- A Phase 1 study of high doses of aminopterin with leucovorin rescue in patients with advanced metastatic Tumors.
- Lack of responsiveness of C3H/HeJ macrophages to lipopolysaccharide: the Cellular basis of LPS-stimulated metabolism.
- Resistance of macrophages from C3H/HeJ mice to the in vitro cytotoxic effects of endotoxin.
- Action of endotoxin on lymphoid Cells.
- Dose limiting extramedullary toxicity of high dose chemotherapy.
- Difference in B Cell mitogen responsiveness between closely related strains of mice.
- Cellular mechanism of endotoxin unresponsiveness in C3H/HeJ mice.
- Gonadotropin-releasing hormone and its receptor in normal and malignant Cells.
- Silibinin causes Cell cycle arrest and apoptosis in human bladder transitional Cell carcinoma Cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleav...
- Migration and invasion of human prostate cancer Cells is related to expression of VEGF and its receptors.
- GnRH-PAP hormonotoxin targets cytotoxicity to prostate cancer Cell lines.
- Proliferative tumor doubling times of prostatic Carcinoma.
- RANDOMIZED TRIAL OF AUTOLOGOUS CellULAR IMMUNOTHERAPY WITH SIPULEUCEL-T IN ANDROGEN DEPENDENT PROSTATE CANCER.
- Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial Carcinoma: results of a multicenter ...
Schools
University Of Texas Southwestern Medical School Program
Brigham and Women39s HospitalMassachusetts General HospitalDanaFarber Cancer Institute Program
National Institutes Of Health NIH
Procedures Preformed
- Thoracentesis
Conditions Treated
- Anemia
- Basal Cell Carcinoma
- Bladder Cancer
- Breast Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Brigham and Women's Hospital -
University of Texas Southwestern Medical School -
Washington University School of Medicine in St. Louis
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1730279415 | |
| NPPES Provider LastName | GLODE | |
| NPPES Provider FirstName | L | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 323.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730279415 |
| Last Name Of The Provider | GLODE |
| First Name Of The Provider | L |
| View All |
Similar Doctors
|
|
Dr. William T. Purcell, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas W. Flaig, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert C. Doebele, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William E. Daniel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael Gordon, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter Kabos, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vibha T. Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Antonio Jimeno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karl D. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose I. Mayordomo, MD
This Doctor is OpenDoctor Recommended.
|